FDA Requires Boxed Warning for All Botulinum Toxin Products
Links shared publicly online about this topic.
- 1,979total visits
FDA Requires Boxed Warning for All Botulinum Toxin Products
fda.gov —
View full resource at fda.gov
Most Recently Shared on June 10, 2009 at 5:04 pm By:
FDA requires boxed warning on all botulinum toxin products: http://bit.ly/Zl93J
Blocked
jama.ama-assn.org — “Blocked” View full resource at jama.ama-assn.org
Most Recently Shared on June 12, 2009 at 7:22 pm By:
FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products http://tinyurl.com/m5d4nv
FDA requires strong ’black box’ warning for Botox, others - - ModernMedicine
modernmedicine.com — “Botulinum toxin products must carry a strong "black box" warning on potentially lethal risks, the U.S. Food and Drug Administration (FDA) announced April 30.” View full resource at modernmedicine.com
Most Recently Shared on May 2, 2009 at 11:57 pm By:
ModernMedicine.com Health Site
FDA requires strong ’black box’ warning for Botox, others http://twurl.nl/cgxego
Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to strengthen warnings - MPR
empr.com — “The FDA has notified healthcare professionals that it is requiring the manufacturers of licensed botulinum toxin products, including Botox and Botox Cosmetic (botulinum toxin type A, from Allergan) and Myobloc (botulinum toxin type B, from Solstice Neurosciences), to strengthen warnings in product labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spreads beyond the injection site.” View full resource at empr.com
Most Recently Shared on April 30, 2009 at 8:05 pm By:
MPR News: Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to streng.. http://tinyurl.com/c674rf
Advertisement
